Overview
Monika Ulamec practices practicing medicine in Zagreb, Croatia.
Ms. Ulamec is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Teratoma of the Mediastinum, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Orchiectomy, and Prostatectomy.
She is actively involved in clinical research, co-authoring 79 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Monika Ulamec
Is Monika Ulamec a top-rated expert for Teratoma of the Mediastinum?
MediFind is an objective health platform that identifies experts based on real-world data. Monika Ulamec is classified as an Distinguished expert for Teratoma of the Mediastinum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Monika Ulamec participate in research or clinical trials?
Yes. Monika Ulamec has published 79 articles and abstracts on conditions like Teratoma of the Mediastinum. You can view a list of Monika Ulamec's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Teratoma of the MediastinumMs. Ulamec isDistinguished. Learn about Teratoma of the Mediastinum.
- Advanced
- Chromophobe Renal Cell CarcinomaMs. Ulamec isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Prostate CancerMs. Ulamec isAdvanced. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Ms. Ulamec isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Renal OncocytomaMs. Ulamec isAdvanced. Learn about Renal Oncocytoma.
- Testicular CancerMs. Ulamec isAdvanced. Learn about Testicular Cancer.
- Experienced
- Bladder CancerMs. Ulamec isExperienced. Learn about Bladder Cancer.
- Darier DiseaseMs. Ulamec isExperienced. Learn about Darier Disease.
- Enlarged Prostate (BPH)Ms. Ulamec isExperienced. Learn about Enlarged Prostate (BPH).
- Familial Prostate CancerMs. Ulamec isExperienced. Learn about Familial Prostate Cancer.
- InsulinomaMs. Ulamec isExperienced. Learn about Insulinoma.
- Neuroendocrine TumorMs. Ulamec isExperienced. Learn about Neuroendocrine Tumor.
- OrchiectomyMs. Ulamec isExperienced. Learn about Orchiectomy.
- Persistent Mullerian Duct SyndromeMs. Ulamec isExperienced. Learn about Persistent Mullerian Duct Syndrome.
- ProstatectomyMs. Ulamec isExperienced. Learn about Prostatectomy.
- Stomach CancerMs. Ulamec isExperienced. Learn about Stomach Cancer.
- Testicular Yolk Sac TumorMs. Ulamec isExperienced. Learn about Testicular Yolk Sac Tumor.
- ThymectomyMs. Ulamec isExperienced. Learn about Thymectomy.
- Uterine FibroidsMs. Ulamec isExperienced. Learn about Uterine Fibroids.
- Von Hippel-Lindau (VHL) SyndromeMs. Ulamec isExperienced. Learn about Von Hippel-Lindau (VHL) Syndrome.